SULT1A1, sulfotransferase family 1A member 1, 6817

N. diseases: 122; N. variants: 13
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C1514422
Disease: Glioblastoma, IDH-Wildtype
Glioblastoma, IDH-Wildtype
0.010 PosttranslationalModification disease BEFREE Our cohort consisted of 39 cases diagnosed as "glioblastoma, IDH-wildtype" of which the MGMT promoter methylation status was analyzed with both methylation-specific PCR and high density DNA methylation array using the STP-27 algorithm. 31784096 2020
CUI: C0013146
Disease: Drug abuse
Drug abuse
0.010 GeneticVariation group BEFREE Forty drugs were significantly affected by the use of PST™ II tubes, including antidepressants (11/26), neuroleptics (9/13), cardiovascular drugs (5/26), anxiolytics and hypnotics (4/25) and some drugs of abuse (5/26). 30439354 2019
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.010 AlteredExpression disease BEFREE Serum levels of AXIN1 and ST1A1 were increased in endometriosis compared with MC (<i>p</i> < 0.001) and healthy controls (<i>p</i> = 0.001), whereas CXCL9 levels were decreased. 30621017 2019
CUI: C0027765
Disease: nervous system disorder
nervous system disorder
0.010 Biomarker group BEFREE NPTs (processing speed [PST], contrast sensitivity [CST], manual dexterity [MDT], and walking speed [WST]) and physical disability-related PROMs (Quality of Life in Neurological Disorders [Neuro-QoL], Patient Determined Disease Steps [PDDS], and Patient-Reported Outcomes Measurement Information System Global-10 [PROMIS-10] physical) were collected as part of routine clinical care. 31759186 2019
CUI: C0036117
Disease: Salmonella infections
Salmonella infections
0.010 Biomarker group BEFREE Sequence analysis also proved the absence of virulence and lysogeny-related genes, which only went to confirm ΦStp1 as a promising therapeutic agent against Salmonella infections. 29478159 2018
CUI: C0043346
Disease: Xeroderma Pigmentosum
Xeroderma Pigmentosum
0.010 GeneticVariation disease BEFREE Genetic polymorphism (glutathione S-transferase M1; T1; P1 (GSTM1; GSTT1; GSTP1); N-acetyltransferase 1; 2 (NAT1; NAT2); cytochrome P450 1B1 (CYP1B1); sulfotransferase 1A1 (SULT1A1); myeloperoxidase (MPO); catechol-O-methyltransferase (COMT); manganese superoxide dismutase (MnSOD); NAD(P)H:quinone oxidoreductase (NQO1); X-ray repair cross-complementing group 1; 3 (XRCC1; XRCC3) and xeroderma pigmentosum complementation group (XPD)) was assessed in peripheral blood lymphocytes. 30042310 2018
CUI: C0702166
Disease: Acne
Acne
0.010 GeneticVariation disease BEFREE The C. acnes-injected mouse ears were covered with a PST MTAM encapsulated with or without <i>S.</i><i>epidermidis</i> in the presence of glycerol. 30577530 2018
CUI: C0860603
Disease: Anxiety symptoms
Anxiety symptoms
0.010 Biomarker phenotype BEFREE The PST helps reduce depressive and anxiety symptoms and may help stabilize glucose and cholesterol up to four months. 28870280 2018
CUI: C2267227
Disease: Bulimia Nervosa
Bulimia Nervosa
0.010 GeneticVariation disease BEFREE In the BN group, haplotype *2 (non7R-TR long-C-C) was associated with higher scores in the three global SCL-90R indices (GSI, PSDI and PST) after Bonferroni correction (p ≤ 0.01 in all instances). 29455021 2018
CUI: C0011884
Disease: Diabetic Retinopathy
Diabetic Retinopathy
0.010 GeneticVariation disease BEFREE In a pilot randomized controlled trial, 40 participants with DR and diabetes distress were allocated to the PST-D or control groups. 28243448 2017
CUI: C0085215
Disease: Ovarian Failure, Premature
Ovarian Failure, Premature
0.010 Biomarker disease BEFREE The aim of this study was to investigate whether polymorphism and expression of CYP17, CYP1A1, COMT and SULT1A1 affected the risk of idiopathic primary ovarian insufficiency (POI) in Chinese women. 28887105 2017
CUI: C0021051
Disease: Immunologic Deficiency Syndromes
Immunologic Deficiency Syndromes
0.010 AlteredExpression group BEFREE We demonstrate that the cytosolic sulfotransferase SULT1A1 is highly expressed in primary human MDMs, and through siRNA knockdown experiments, we show that this enzyme promotes infection of MDMs by single cycle VSV-G pseudotyped human HIV-1 and simian immunodeficiency virus vectors and by replication-competent HIV-1. 26906565 2016
Squamous cell carcinoma of esophagus
0.010 GeneticVariation disease BEFREE The study indicates that, unlike SULT1A1*2 and SULT1A2*2, the polymorphism of CYP1A1*4 is associated with ESCC risk. 26455829 2016
CUI: C0038644
Disease: Sudden infant death syndrome
Sudden infant death syndrome
0.010 GeneticVariation disease BEFREE After correction for multiple testing, one SNP retained a nominally significant association with seasonal SIDS: rs1801030 in the phenol sulfotransferase 1A1 gene (subgroup: death occurring during summer). 26198620 2015
CUI: C0085669
Disease: Acute leukemia
Acute leukemia
0.010 Biomarker disease BEFREE Polymorphisms in CYP1B1, CYP3A5, GSTT1, and SULT1A1 Are Associated with Early Age Acute Leukemia. 25992585 2015
CUI: C0340100
Disease: High altitude pulmonary edema
High altitude pulmonary edema
0.010 Biomarker disease BEFREE For the first time, we also report the possible consideration of SULT1A1, as a biomarker for the diagnosis of high altitude pulmonary edema (HAPE). 26022216 2015
CUI: C4054727
Disease: Infant Acute Lymphoblastic Leukemia
Infant Acute Lymphoblastic Leukemia
0.010 GeneticVariation disease BEFREE SULT1A1 (c.638G>A) was associated to infant acute lymphoblastic leukemia and acute myeloid leukemia (AML) risk in males (additive model: aOR = 0.52; 95% CI: 0.29-0.95, p = 0.03; dominant model: aOR = 2.18; 95% CI: 1.17-4.05, p = 0.01, respectively). 25992585 2015
CUI: C0027794
Disease: Neural Tube Defects
Neural Tube Defects
0.010 GeneticVariation group BEFREE Maternal SULT1A1 polymorphism is associated with the risk of fetal NTDs, and has an additive-scale interaction with maternal IAPCC exposure for NTD risk. 24307569 2014
CUI: C3539878
Disease: Triple Negative Breast Neoplasms
Triple Negative Breast Neoplasms
0.010 AlteredExpression disease BEFREE Expression of the STP axis correlates with low REST protein levels in human TNBCs and poor clinical outcome for TNBC patients. 25453754 2014
CUI: C4722518
Disease: Triple-Negative Breast Carcinoma
Triple-Negative Breast Carcinoma
0.010 AlteredExpression disease BEFREE Expression of the STP axis correlates with low REST protein levels in human TNBCs and poor clinical outcome for TNBC patients. 25453754 2014
CUI: C0242788
Disease: Breast Neoplasms, Male
Breast Neoplasms, Male
0.010 AlteredExpression group BEFREE Based on the evidence that the level of SULT1A1 enzyme activity is correlated with CNV, our data suggest that in male breast tumors SULT1A1 activity may be decreased. 23711090 2013
Environment-Related Malignant Neoplasm
0.010 GeneticVariation disease BEFREE In conclusion, SULT1A1 Arg213His polymorphism, ethnicity, smoking may modulate environment-related cancer risk. 21670965 2012
CUI: C0600142
Disease: Hot flushes
Hot flushes
0.010 Biomarker phenotype BEFREE There were significant interactions between SULT1A1*3 and hot flashes (P < 0.001) and between SULT1A1*2 and depressive symptoms (P = 0.007) on menopausal stage, and there were race-specific effects of SULT1A1*2, SULT1A1*3, CYP1B1*3, and CYP3A4*1B on menopause. 20505544 2011
CUI: C0206698
Disease: Cholangiocarcinoma
Cholangiocarcinoma
0.010 GeneticVariation disease BEFREE Also, the ESR2 rs4986938 (38 bp 3' of STP) GG genotype was associated with a higher risk of bile duct cancer (OR = 3.3, 95% CI 1.3-8.7) compared with the AA genotype, although this estimate was based on a small number of subjects. 20172949 2010
CUI: C0346153
Disease: Breast Cancer, Familial
Breast Cancer, Familial
0.010 GeneticVariation disease BEFREE This case control study investigated whether polymorphisms of estrogen metabolizing genes CYP1A1 MspI, CYP17 MspAI, COMT Val(158) Met, and SULT1A1 Arg(213) His have any role in familial breast cancer susceptibility risk. 19863350 2010